Product Details
Jyna Dolutegravir, Lamivudine and Tenofovir Disoproxil
Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate50 mg; 300 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Jyna Pharma Ltd
NRN
C4-0363
Status
Active
Composition
ATC Code
J05AR27
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
Product Description
424 Jyna Dolutegravir, Lamivudine And Tenofovir Disopr C4-0363 Dolutegravir, Lamivudine And Tenofovir Disoproxil Dolutegravir Sodium = Sodium (Ras)--{[(-Difluorophenyl)Methyl]Carbamoyl}-- Methyl-,-Dioxo-,,A-Hexahydro- H-Pyrido[’’:]Pyrazino[-B][,]Oxazin--Olate. = Chfnnao Lamivudine = (H)-Pyrimidinone,-Amino--[-(Hydroxyl Methyl)-,-Oxathiolan -Yl]-, (R-Cis)-; Or (-)--[(R,S)--(Hydroxylmethyl)-,-Oxathiolan-Yl]-Cytosine Or (-)--Amino--[(R,S)--(Hydroxymethyl)-,-Oxathiolan-Yl]-Pyrimidin-(H)-One = Chnos Tenofovir Disoproxil Fumarate = -[(R Anti-Infectives Oral (4r,12as)-9-{2,4--4- 6,8-3,4,6,8,12,12a-- 2h-[1’,2’:4,5][2,1-B][1,3]-. = 2(1h)-1-[2--1,3- -5-Yl]-, (2r-Cis)-; Or (-)-1-[(2r,5s)-2-)-1,3--5-Yl]-R (-)-4-Amino-1-[(2r,5s)-2-)-1,3--5--2(1h)- = 9-[(R Tablet, Film Coated Prescription Only Medicine (Pom) Jyna Pharma Ltd Laurus Labs India 2021-05-07 2026-05-06
Manufacturer Name
Laurus Labs Limited
Manufacturer Country
INDIA
Approval Date
2021-05-07
Expiry Date
2026-05-06